NCAM1 and chronic myelogenous leukemia, BCR-ABL1 positive: Notably, in chronic myeloid leukemia, a unique surface expression profile has been identified in LSCs, characterized by consistent expression of markers such as CD25+, CD26+, CD56+, and IL-1RAP+ [43].